Literature DB >> 16601981

Inducible co-stimulator (ICOS) is upregulated in experimental autoimmune uveoretinitis.

Lin Xing1, Peizeng Yang, Changyou Wu, HaoLi Jin, Xuan Chen, Yang Gao, Bing Li, Xiangkun Huang, Hongyan Zhou.   

Abstract

PURPOSE: To study the expression of inducible co-stimulator (ICOS) and its association with T cell effector function in experimental autoimmune uveoretinitis (EAU).
METHODS: Eighteen Lewis rats were immunized by retinal S-antigen (50 microg) emulsified in complete Freund's adjuvant (CFA). Twelve normal rats served as normal controls and 18 receiving injection of CFA and PBS as CFA controls for studying the influence of CFA on the expression of ICOS in CD4+CD25+ T cells. ICOS expression on cells from the spleens, inguinal nodes and retinae on day 0 (normal rats), 7, 13 and 21 was investigated using fluorescent quantitative real-time-PCR and Western blot. Expression of B7RP-1, an ICOS ligand, was also studied by Western blot. The phenotype of the cells from the aforementioned three tissues was identified with flow cytometry using antibodies to ICOS, CD4 and CD25. ICOS+ cells from the lymph nodes, and spleens on day 13 were magnetically sorted and cultured with S-antigen to study the cytokines production with enzyme-linked immunosorbent assay. RESULT: An obvious uveitis was induced in all the immunized rats on day 13 after S-antigen immunization. The mRNA and protein of ICOS were scarcely detectable in normal rat spleens. In EAU rats, an up-regulation of ICOS could be observed on day 7 and was very pronounced on day 13, followed by a decrease on day 21 in the spleens, draining nodes and retinae. Similarly, B7RP-1 expression seemed to be up-regulated during EAU. Flow cytometry showed that ICOS+ cells were mostly CD4 positive. Kinetics of ICOS+CD4+CD25+ T cells was similar to that of ICOS+ cells. CFA alone was also able to induce increased expression of ICOS in CD4+CD25+ T cells. IFN-gamma was secreted predominantly by ICOS+ T cells.
CONCLUSION: ICOS expression is up-regulated in association with T cell effector capacity in EAU. It is presumed that the ICOS/B7RP-1 costimulatory pathway may play a role in the development of EAU.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601981     DOI: 10.1007/s00417-005-0207-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  Functional responses and costimulator dependence of memory CD4+ T cells.

Authors:  C A London; M P Lodge; A K Abbas
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Enhancement of CD8+ T cell responses by ICOS/B7h costimulation.

Authors:  J J Wallin; L Liang; A Bakardjiev; W C Sha
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

3.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

4.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.

Authors:  M M Swallow; J J Wallin; W C Sha
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

5.  A simple and rapid method for isolation of retinal S antigen.

Authors:  C Dorey; J Cozette; J P Faure
Journal:  Ophthalmic Res       Date:  1982       Impact factor: 2.892

6.  Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease.

Authors:  A G Tesciuba; S Subudhi; R P Rother; S J Faas; A M Frantz; D Elliot; J Weinstock; L A Matis; J A Bluestone; A I Sperling
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

7.  Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation.

Authors:  Hideyuki Iwai; Yuko Kozono; Sachiko Hirose; Hisaya Akiba; Hideo Yagita; Ko Okumura; Hitoshi Kohsaka; Nobuyuki Miyasaka; Miyuki Azuma
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

8.  Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.

Authors:  A J McAdam; T T Chang; A E Lumelsky; E A Greenfield; V A Boussiotis; J S Duke-Cohan; T Chernova; N Malenkovich; C Jabs; V K Kuchroo; V Ling; M Collins; A H Sharpe; G J Freeman
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

9.  Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS.

Authors:  S K Yoshinaga; M Zhang; J Pistillo; T Horan; S D Khare; K Miner; M Sonnenberg; T Boone; D Brankow; T Dai; J Delaney; H Han; A Hui; T Kohno; R Manoukian; J S Whoriskey; M A Coccia
Journal:  Int Immunol       Date:  2000-10       Impact factor: 4.823

10.  Inducible costimulator is essential for collagen-induced arthritis.

Authors:  Roza I Nurieva; Piper Treuting; Julie Duong; Richard A Flavell; Chen Dong
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

View more
  2 in total

1.  Down-regulation of inducible co-stimulator (ICOS) by intravitreal injection of small interfering RNA (siRNA) plasmid suppresses ongoing experimental autoimmune uveoretinitis in rats.

Authors:  Yongsheng Hou; Lin Xing; Shaoying Fu; Xiaoning Zhang; Jingjing Liu; Hongling Liu; Bingjie Lv; Hao Cui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-06       Impact factor: 3.117

2.  Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand.

Authors:  Kathryn L Pepple; Leslie Wilson; Russell N Van Gelder; Marina Kovaleva; Obinna C Ubah; John Steven; Caroline J Barelle; Andrew Porter
Journal:  Transl Vis Sci Technol       Date:  2019-09-18       Impact factor: 3.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.